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Background: The burden of pediatric critical illness and resource utilization by children
with critical illness in resource limited settings (RLS) are largely unknown. Without specific
data that captures key aspects of critical illness, disease presentation, and resource
utilization for pediatric populations in RLS, development of a contextual framework for
appropriate, evidence-based interventions to guide allocation of limited but available
resources is challenging. We present this methods paper which describes our efforts
to determine the prevalence, etiology, hospital outcomes, and resource utilization
associated with pediatric acute, critical illness in RLS globally.
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Methods: We will conduct a prospective, observational, multicenter, multinational
point prevalence study in sixty-one participating RLS hospitals from North, Central and
South America, Africa, Middle East and South Asia with four sampling time points
over a 12-month period. Children aged 29 days to 14 years evaluated for acute
illness or injury in an emergency department) or directly admitted to an inpatient
unit will be enrolled and followed for hospital outcomes and resource utilization for
the first seven days of hospitalization. The primary outcome will be prevalence of
acute critical illness, which Global PARITY has defined as death within 48 hours
of presentation to the hospital, including ED mortality; or admission/transfer to an
HDU or ICU; or transfer to another institution for a higher level-of-care; or receiving
critical care-level interventions (vasopressor infusion, invasive mechanical ventilation,
non-invasive mechanical ventilation) regardless of location in the hospital, among children
presenting to the hospital. Secondary outcomes include etiology of critical illness,
in-hospital mortality, cause of death, resource utilization, length of hospital stay, and
change in neurocognitive status. Data will be managed via REDCap, aggregated, and
analyzed across sites.
Discussion: This study is expected to address the current gap in understanding of
the burden, etiology, resource utilization and outcomes associated with pediatric acute
and critical illness in RLS. These data are crucial to inform future research and clinical
management decisions and to improve global pediatric hospital outcomes.
Keywords: pediatric critical illness, acute pediatric care, critical care, outcome, low-and lower-middle-income
countries, resource utilization, low resource setting

INTRODUCTION

studies to determine the prevalence of specific pediatric acute
critical illnesses: the Pediatric Acute Lung Injury Ventilation
(PALIVE) and Pediatric Acute Respiratory Distress Syndrome
Incidence and Epidemiology (PARDIE) studies estimated
the prevalence of acute pediatric lung injury (10, 15) the
International Survey of Critically Ill Children with Acute
Neurological Insults (PANGEA) estimated the prevalence of
new neurologic injury due to a variety of etiologies (6); and
the Sepsis Prevalence, Outcomes, and Therapies (SPROUT)
study estimated the prevalence of severe pediatric sepsis (18).
While each of these studies contributed significant knowledge
about specific critical illnesses, they failed to capture the true
global burden of disease and resource utilization within and
across LMICs. These studies also required Pediatric Intensive
Care Unit (PICU) admission as an inclusion criterion, limiting
participation to hospitals with intensive care units. This likely
resulted in an underestimation of disease prevalence and
mortality in RLS where critical illness is often managed outside of
formal intensive care units (2). Additionally, there is significant
overlap between illnesses (e.g., pneumonia is a frequent cause
of sepsis) and resources required (e.g., mechanical ventilation
may be required to support trauma and septic patients) to
treat pediatric acute critical illness; therefore, a narrow, diseasespecific focus fails to capture both the burden of acute critical
illness overall nor does it provide a realistic estimate of resource
required to deliver critical care to these patients.
For these reasons the true burden of and outcomes associated
with pediatric acute critical illness in RLS have not been

Over 80 percent of the annual 6.4 million global deaths
in children less than 14 years of age occur in low- and
middle-income countries (LMICs) with limited resources (1).
These deaths are predominantly a result of acute illnesses
– sepsis, pneumonia, and trauma – that can be successfully
managed with basic, intensive care interventions, such as
fluid resuscitation, ventilator support, and transfusion of blood
products. Unfortunately, though pediatric acute critical illnesses
are the leading causes of death and disability for children outside
of the neonatal period globally, acute and critical care services are
not universally available in resource-limited settings (RLS) (2–7).
A lack of acute and critical care resources is directly associated
with worse outcomes, including increased mortality, in children
(6–12). Furthermore, this global disparity not only exists with
respect to available resources, but also in the availability of data.
The true burden and incidence of pediatric acute critical illness
is unknown (2, 3, 7, 13–17). Without specific data that captures
etiology of acute critical illness and resource utilization in RLS,
we cannot develop a contextual framework for appropriate,
evidence-based interventions, or appropriately allocate limited
but available resources in RLS.
Point prevalence studies are a valuable study design to
prospectively gather individual-level data, determine disease
prevalence, and measure variability in outcomes and resource
utilization across many geographic regions and healthcare
settings. Recently, there have been several global point prevalence
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previously characterized. As a result, the overall health impact
of pediatric acute critical illness in RLS is not known. To better
understand the burden of pediatric acute critical illness and
associated resource utilization in RLS, we propose the Pediatric
Acute cRitical Illness point prevalence sTudY; Global PARITY.
The overarching objectives of the study are to 1) engage the
global pediatric critical care community to establish baseline
frequencies and outcomes of common conditions leading to
morbidity and mortality of children in RLS, 2) inform a
prospective research agenda to challenge the status quo and
discover breakthroughs in care to improve pediatric outcomes
globally, and 3) measure the burden of pediatric acute critical
illness in RLS. Addressing these data gaps are a crucial first to set
future clinical research, health delivery, and resource allocation
priorities for RLS globally.

TABLE 1 | Participating sites by country and global PARITY-designated region.
Country

METHODS
Study Design and Setting
A prospective, observational, multicenter, multinational point
prevalence study will be conducted in resource-limited hospitals
in North, Central, and South America, Africa, the Middle
East, and South Asia over four sampling time periods to
capture seasonal variation. The specific aims of this study
are to determine 1) the etiology and prevalence of pediatric
acute critical illness among children presenting to participating
hospitals in RLS; 2) measure hospital outcomes (mortality, length
of stay) in children with acute critical illness in RLS; 3) determine
hospital resource utilization by children with acute critical illness;
and 4) determine the current resources available to provide acute
critical care across RLS.
RLS are characterized by a lack of funds to cover health
care costs, resulting in: limited access to medication, equipment,
supplies, and devices; less-developed infrastructure; and fewer
or less-trained personnel. Resource limitations at each site will
be assessed by a separate Hospital Resource Survey (7). Eligible
sites will: self-identify as a RLS; be an acute care hospital; provide
emergency and inpatient care to a general population of children
with acute illnesses (i.e., not a specialty hospital); have a reliable
internet connection or cellular service for uploading data; have
a member of the local research team who can communicate
in and understand English; have an established Institutional
Review Board (IRB) or ethical approval process; have previous
experience with clinical research and data collection; have
the ability to support or apply for support for study-related
costs. Hospitals will be recruited via established relationships
from the Global Health subgroup of the Pediatric Acute Lung
Injury and Sepsis Investigators’ (PALISI) Research Network
(www.palisiglobalhealth.org), the St. Jude Global Critical Care
Program (www.stjude.org/global), and the Red Colaborativa
Pediátrica de Latinoamérica (LARed Network). At time of
this manuscript, 61 sites from 27countries in 8 regions have
committed to participation (Table 1, Figure 1). The study is
coordinated by the Department of Pediatrics at the University
of Maryland and has been deemed exempt by the University of
Maryland Institutional Review Board (IRB, HP-00086107).
All children presenting to the Emergency Department (ED),
or equivalent acute hospital receiving unit, or who are directly
Frontiers in Pediatrics | www.frontiersin.org

Number
of
participating
sites

Global PARITY region

Argentina

5

Spanish-speaking South America

Barbados

1

North America/Caribbean/Central America

Bolivia

1

Spanish-speaking South America

Brazil

1

Portuguese-speaking South America

Colombia

12

Spanish-speaking South America

Ethiopia

2

West Africa/Ethiopia

Ghana

8

West Africa/Ethiopia

Guatemala

1

North America/Caribbean/Central America

Haiti

1

Francophone Countries

India

2

Middle East/India/Pakistan

Indonesia

1

Southeast Asia

Kenya

1

East/Central Africa

Lebanon

1

Middle East/India/Pakistan

Malaysia

1

Southeast Asia

Mali

1

Francophone Countries

Mexico

2

North America/Caribbean/Central America

Mongolia

1

Southeast Asia

Nigeria

3

West Africa/Ethiopia

Pakistan

3

Middle East/India/Pakistan

Paraguay

1

Spanish-speaking South America

Peru

2

Spanish-speaking South America

Rwanda

3

East/Central Africa

Tanzania

1

East/Central Africa

Thailand

1

Southeast Asia

Turkey

1

Middle East/India/Pakistan

Uganda

2

East/Central Africa

Uruguay

2

Spanish-speaking South America

admitted to a participating site hospital will be screened during
a 24-h period on four separate days within four epochs over a
12-month period for inclusion and exclusion criteria. Inclusion
criteria will include children aged 29 days to 14 years of age
evaluated in the ED for an acute illness or injury or directly
admitted to an inpatient unit. Children who are evaluated in
the ED and discharged home after evaluation, who die in the
ED, or are evaluated and transferred to a higher level of care
will be included. This number will serve as the total population
(denominator) to calculate the prevalence.
Children presenting for a scheduled follow-up visit,
vaccinations, suture removal (or other non-acute complaint),
children with a corrected gestational age less than 42 weeks,
and children who present to the ED and are pronounced
dead on arrival will be excluded. Neonates and infants up to
28 days will not be included in this study as the etiology of
critical illness and resource requirements to manage neonates
and young infants differs significantly from that of older
children. Since the upper age limit of what defines a pediatric
patient varies by site and region, 14 years was chosen as
the upper limit of age, as patients 14 years and younger are
generally considered to be children regardless of setting. All
children meeting inclusion criteria and no exclusion criteria
3
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FIGURE 1 | World map of participating sites.

the medical record, per exempt status of the IRB, during
the study: hospital characteristics including average number of
patient encounters and admissions, types of inpatient units,
available human resources, available infrastructure including
healthcare devices, medications and laboratory resources; patient
characteristics including severity of illness, anthropometrics
(weight, height, mid-upper arm circumference), comorbidities
(HIV status, congenital heart disease, malnutrition), presenting
vital signs, routine laboratory test results, imaging results, and
the Pediatric Overall Performance Category (POPC) (5) prior
to the current illness; hospital resource utilization including use
of blood transfusion, fluid bolus, vasoactive agents, non-invasive
positive pressure ventilation, oxygen, mechanical ventilation,
ICU admission, and antibiotic administration; and outcomes
including discharge home, transfer to a higher level of care within
the hospital, transfer to another hospital, death, final hospital
diagnosis, length of stay, cause of death (if applicable), and the
POPC at the time of discharge. For the selected case report
forms, see supplements entitled 1) Initial Intake Survey, 2) Daily
Assessment Survey, 3) Final Outcomes Survey.

will be enrolled. Due to the IRB exempt status, consent is
not required.
Patients who are admitted to the hospital (e.g., general
pediatric ward, high dependency unit [HDU], or intensive
care unit [ICU]) either directly or through the ED will be
followed daily for up to 7 days to determine daily resource
utilization. Admitted patients will also be followed until the
time of discharge, death, transfer or hospital day 30, whichever
occurs first, to determine hospital outcomes. These admitted
patients will be the numerator to calculate the overall prevalence
of hospitalizations.

Data Collection and Management
All data will be collected and managed via REDCap (Research
Electronic Data Capture); a secure, web-based application and
electronic data capture tool hosted at the University of Maryland
(19, 20). No patient-identifying data will be collected. Prior
to data collection, a pilot will be conducted at each site
to identify challenges in data acquisition and to test study
procedures. Study data will be collected using a hospital resource
survey, an initial intake survey, a daily resource utilization
survey (to be completed daily from the day of presentation
up to hospital day seven), and a final outcomes survey (see
Supplementary Material). The hospital resource survey is an
adapted version of a previously published (7) survey that
aims to assess aspects of resource availability, the presence of
a basic research infrastructure including ethical and/or IRB
approval mechanisms, and the availability of a local site principal
investigator (PI). The following data will be collected from

Frontiers in Pediatrics | www.frontiersin.org

Outcomes
The primary outcome of interest is prevalence of pediatric acute
critical illness, defined as death within 48 h of presentation
to the hospital, including ED mortality; or admission/transfer
to an HDU or ICU; or transfer to another institution for a
higher level-of-care; or receiving critical care-level interventions
(vasopressor infusion, invasive mechanical ventilation, noninvasive mechanical ventilation) regardless of location in the

4
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DISCUSSION

hospital. Secondary outcomes include etiology of critical illness,
in-hospital mortality, cause of death, resource utilization, length
of hospital stay, and change in neurocognitive status from
premorbid state from admission to discharge POPC.

Global PARITY will address the current gap in knowledge
regarding the burden of pediatric acute critical illness and
hospital resource utilization in RLS. In contrast to previous
point prevalence studies estimating the prevalence of specific
pediatric critical illnesses (e.g., ARDS, sepsis), Global PARITY
aims to measure the burden of all pediatric acute critical
illness. Additionally, by expanding the definition of critical
illness to include PICU admission, intensive care-level resource
utilization, and/or early hospital mortality, the Global PARITY
definition is more inclusive and likely to capture critical
illness managed in hospitals without formal intensive care
units. To our knowledge, this is the first global pediatric
point prevalence study to include settings without formal
intensive care services and aimed at measuring the prevalence
of pediatric critical illness as one entity instead of separate,
individual diagnoses.
There are some anticipated limitations to our study. Our
study shares limitations common to all point prevalence studies,
including inability to account for prehospital mortality or
resource utilization. This may result in an underestimation
of disease prevalence and resource requirements, especially in
those that have a fulminant course or in patients who lack
quick access to a hospital setting. Likewise, while the Global
PARITY definition of acute critical illness is more inclusive
than prior global pediatric point prevalence studies, it has not
been previously studied or validated. It is possible that this
definition may over or underestimate the true burden of critical
illness. However, similar definitions have been used in other

Statistical Analysis
Data will be analyzed on all subjects who meet inclusion
criteria. Descriptive analyses will summarize population-level
information. Regression modeling will be used to explore risk
factors associated with critical illness (primary outcome), inhospital mortality, resource utilization, length of hospital stay,
and change in neurocognitive status from baseline (secondary
outcomes). These analyses will include adjustments for clustering
(facility-level, region-level), time-varying variables, and timeinvariant variables. Variables will be chosen for evaluation in
multivariable models based on their empirical significance in
the literature (age, sex, severity of illness, HIV status, anemia,
malnutrition) and their performance in univariable models.

Secondary Analyses
Owing to the international and collaborative nature inherent to
this study, investigators participating in this study were able to
submit proposals for secondary analysis. Proposals for secondary
analysis were requested from participating site investigators to
query the data generated by Global PARITY to address important
questions and gaps not addressed by primary and secondary
outcomes of the study. The proposals were reviewed by the
Scientific Committee of the Global Health Subgroup; and, a total
of 15 proposals were accepted. The list of approved secondary
analyses are listed in Table 2.

TABLE 2 | Global parity secondary analyses.
Lead investigators

Location

Topic or Theme

1. Asya Agulnik

Global

Burden of critical illness in cancer compared to other patients

2. Enkhtur Sh, Solongo.O, Dulamragchaa.Ch

Mongolia

Epidemiology and outcomes for pediatric acute respiratory distress, sepsis and
sepsis-like diseases

3. Shubhada Hooli, Christian Umuhoza

Global

Prediction modeling and scoring systems for mortality in critical illlness

4. Kandamaran Krishnamurthy, Seetharaman Hariharan

Caribbean

Ways to improve education with ethical dilemmas especially when futility reached

5. Onah Stanley et al.

Nigeria

Metabolic derangements and pathogen specific diseases

6.Sofia Esposto et al.

Global

Time to antibiotics in pneumonia

7. Fiona Muttalib

Global

Association between resource availability at the sites and resource
utilization/outcomes

8. Teresa Kortz

Global

Predictive success of existing clinical scores developed for RMICs at identifying
children at risk of death

9. John Appiah, Adrian Holloway

Global

Blood transfusion delivery in sepsis and influence on patient outcomes

10. Ariet Figueroa et al.

Global

Early measurement of Age adjusted Shock Index to predict outcomes in
non-trauma pediatric patients

11. Madiha Raees, Ericka Fink

Global

Epidemiology, resource use, and outcomes of children with neurocritical illness

12. Sofia Esposto et al.

Global

Characteristics of patients and the factors that determine the onset of empiric
antibiotic therapy in sepsis

13. Sebastián González-Dambrauskas et al.

Latin America Caribbean

Outcomes and resources between two geographical different locations

14. Tigist Bacha Heye

Global

Presentation, Epidemiology, and Outcomes in Sepsis

15. Kenneth Remy, Tex Kissoon

Global

PP of sepsis, the presence of adequate antimicrobials, factors leading toward
increased sepsis burden, and understand comparative mortality associated with
certain available supportive therapies in each LMIC for patients with sepsis.
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especially those with resource limitations. The implementation
of such interventions could then be used for targeted capacitybuilding across resource-limited settings and has the potential
to significantly reduce childhood morbidity and mortality due to
acute critical illness globally.

multicenter studies (19, 21) in RLS, and we expect to capture
the majority of critical illness and associated hospital resource
utilization in these patients. Further, while we tried our best
to recruit centers from a wide range of countries and regions,
we know that there can be disparities within countries based
on region, socioeconomic status and type of healthcare facility
(such as public vs. private). Thus, our study is still susceptible to
selection bias and participating centers may not fully represent
the epidemiology of pediatric acute critical illness or resource
utilization patterns in a given country or region. Additionally,
while we broadened eligible site criteria to include hospitals
with or without a formal intensive care unit, the current site
requirements (English language, resources, internet connectivity,
available Principal Investigator) may still be too burdensome for
some sites in RLS to participate. As a result, our study may
underestimate the true impact of pediatric acute critical illness,
as non-participating sites are likely more resource-limited than
those able to meet study criteria. To address this limitation,
we are applying for pilot funds to help defer study-related
costs at participating sites. We also plan to further explore the
reasons site non-participation in future studies. Regardless of
these limitations, the results of our study will be the starting
point for a generation of urgently need new research and
interventional studies.
Global PARITY represents a unique opportunity to engage
pediatric clinicians across the world. Only with a large,
concerted effort can we, as a global pediatric community,
start to understand the spectrum of acute critical illness and
its association with childhood morbidity and mortality across
resource-variable settings. The results of Global PARITY will
inform a prospective, inclusive, global research agenda that
includes children around the world, regardless of local resource
availability. The data from this study will challenge the status
quo and move us toward achieving the long-term goal to
develop a body of evidence to support basic, universal, costeffective critical care interventions appropriate for all settings,
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